Global Neuralgia Treatment Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029

“Global Neuralgia Treatment Market” is the title of an upcoming report offered by MarketResearch.Biz. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in to various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global neuralgia treatment market has been segmented on the basis of treatment, end-use, as well as regions and countries.

Request Covid - 19 Impact

Overview:

Neuralgia is a stabbing, burning, and often severe pain due to an irritated or damaged nerve. The nerve may be anywhere in the body, and the damage may be caused by several factors, including: aging, diseases such as multiple sclerosis or diabetes, an infection such as shingles, etc.

Dynamics:

The increasing prevalence of diseases such as diabetes, etc., is a primary factor that is expected to increase the demand for neuralgia treatments, thereby, fueling future revenue growth opportunities for the global neuralgia treatment market in the process.

Moreover, the growing incidence rate of trigeminal neuralgia is also another factor that is slated to have a significant influence on the revenue growth of the global neuralgia treatment market in the foreseeable future.

However, in light of the recent COVID-19 outbreak, the operations of numerous industries have been either temporarily halted or are functioning with a minimal workforce due to enforced lockdowns and imposed restrictions by respective governing bodies. The global neuralgia treatment industry is no different, and this factor is expected to negatively impact on market growth in the years to come.

Nonetheless, increasing investments being made by key industry players to develop improved methods of treatment and other approaches to better patient care is a factor that is anticipated to boost market growth prospects of the global neuralgia treatment market in the years to come.

Segmentation of the global neuralgia treatment market is as follows:

In terms of treatment, the surgery-based treatment segment accounted for the maximum number of revenue shares of the global neuralgia treatment market in 2020, and is indicative of indexing a high CAGR in the years to come. Among the surgery segment, the Microvascular Decompression (MVD) segment accounted for the maximum number of revenue shares.

On the basis of end-use, the hospitals & clinics segment constituted the majority number of revenue shares of the global neuralgia treatment market in 2020, due to the increasing number of surgical procedures being carried out at these facilities, as well as the growing number of neuralgia cases being reported at these locations. However, the ambulatory surgery centers segment is anticipated to register the fastest rate of revenue growth over the forecast period, due to the increasing demand for reduced hospital stay periods.

Regional Segmentation and Analysis:

North America accounted for the highest number of revenue shares of the global neuralgia treatment market in 2020, and is slated to register considerable growth over the forecast period.  This can be attributed to the vast number of market players, as well as the rising incidence rate of neuralgia in this region. However, the markets in the Asia Pacific region are anticipated to register the fastest rate of revenue growth over the next 10 years, owing to factors such as the increasing prevalence of diabetes, as well as booming geriatric population figures of this respective region.

Segmentation of the Global Neuralgia Treatment Market:

Segmentation by Treatment:

• Drug Based
• Anticonvulsant Medicines
• Tricyclic Antidepressants
• Surgery
• Radiofrequency Thermal Lesioning
• Stereotactic Radiosurgery
• Microvascular Decompression
• Others

Segmentation by End-Use:

• Hospital & Clinics
• Ambulatory Surgery Centers
• Others

Segmentation by Regions:

• North America
• Europe
• APAC
• South America
• MEA

• GlaxoSmithKline PLC
• Pfizer Inc.
• Novartis AG
• Biogen Inc.
• Cadila Healthcare Limited (Zydus Cadila)
• Lundbeck Pharmaceuticals LLC